Physician profile
Jeffrey R Marcus
NPI 1063596948
$3,327,329.60
in general payments reported to CMS, 2019-2025
18 companies · $505K in 2025
The $505K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501K · 2020: $475K · 2021: $461K · 2022: $445K · 2023: $497K · 2024: $442K · 2025: $505K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Food and Beverage: $2,203 · Entertainment: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,441,861.22 |
| Food and Beverage | $2,202.66 |
| Entertainment | $165.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,322,177.87 | 2019-2025 | Smartlock |
| Kls-Martin L.P. | $1,099.60 | 2020-2024 | |
| Allergan, INC. | $938.05 | 2019-2022 | |
| Abbvie INC. | $899.83 | 2023-2025 | |
| Mentor Worldwide LLC | $561.69 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $267.83 | 2019-2023 | |
| Integra Lifesciences Corporation | $228.34 | 2021-2023 | Durasorb Monofilament Mesh |
| Dilon Technologies, INC. | $146.24 | 2024 | Hemoblast Bellows |
| Axogen | $141.86 | 2020 | |
| Biocomposites INC | $137.18 | 2025 | Stimulan |
| Rti Surgical, INC | $125.93 | 2023 | |
| Sientra, INC. | $114.66 | 2022 | |
| Baxter Healthcare | $106.75 | 2019 | |
| Ethicon US, LLC | $93.66 | 2024 | Vicryl |
| Medtronic, INC. | $91.12 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $87.59 | 2020 | |
| Tei Medical INC. | $60.09 | 2019 | |
| Tela Bio, INC. | $51.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.